BLT
Click for more information
0.00% 2.6¢ benitec biopharma limited

Trial time table, page-6

  1. thecroc101
    2,129 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    01/02/16
    22:24
    Post #: 16917789
    BLT future gets bleaker and bleaker - may explain recent selling

    http://www.fiercepharma.com/story/m...ombo-it-preps-battle-gilead-abbvie/2016-01-29

    Merck sets $54K list price for hep C combo as it preps for battle with Gilead, AbbVie

    January 29, 2016 | By Carly Helfand

    Industry watchers have long been speculating on how Merck would take on heavyweights Gilead ($GILD) and AbbVie ($ABBV) when it priced its new hep C regimen. And now, they have their answer: Undercut them. Big-time.
    BLT Price at posting: 27.0¢ Sentiment: Sell Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Trump is President Again: What Does This Mean for Crypto?
right-arrow Created with Sketch.
NEWS Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
right-arrow Created with Sketch.
3DA To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels
right-arrow Created with Sketch.
NEWS Update on the ASX' most anticipated drill campaign
right-arrow Created with Sketch.
EQN Equinox Resources reports outstanding naturally occurring antimony grade at Alturas Project
right-arrow Created with Sketch.
NEWS Imugene kicks off Australian trial for blood cancer treatment
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.